{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:41:44Z","timestamp":1784860904266,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.08.023","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T18:22:19Z","timestamp":1409077339000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability"],"prefix":"10.1016","volume":"71","author":[{"given":"Sara","family":"Vianello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bouyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sebri\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Boerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Herbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Roulot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Fromes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"de la Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.08.023_bb0005","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.1013077107","article-title":"Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy","volume":"107","author":"Adamo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.023_bb0010","first-page":"738","article-title":"Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort","volume":"20","author":"Archer","year":"2006","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2613.2010.00750.x","article-title":"Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy","volume":"92","author":"Au","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mcn.2008.12.011","article-title":"Truncated dystrophins can influence neuromuscular synapse structure","volume":"40","author":"Banks","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2014.08.023_bb0025","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.20425","article-title":"Systemic administration of L-arginine benefits mdx skeletal muscle function","volume":"32","author":"Barton","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2009.07.013","article-title":"MALDI reveals membrane lipid profile reversion in MDX mice","volume":"36","author":"Benabdellah","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.023_bb0035","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1006\/jmcc.1999.1018","article-title":"Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy","volume":"31","author":"Bia","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and genetics of dystrophin and dystrophin-related proteins in muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2014.08.023_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1529-8027.2009.00205.x","article-title":"Excitability properties of motor axons in the maturing mouse","volume":"14","author":"Boerio","year":"2009","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.nbd.2014.08.023_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0055","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0608277104","article-title":"Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy","volume":"104","author":"Brunelli","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.023_bb0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/nbdi.1999.0256","article-title":"Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy","volume":"6","author":"Chaubourt","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.023_bb0065","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.febslet.2004.12.081","article-title":"alpha7B integrin changes in mdx mouse muscles after L-arginine administration","volume":"579","author":"Chazalette","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2014.08.023_bb0070","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1161\/CIRCULATIONAHA.105.577619","article-title":"Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs","volume":"112","author":"Colan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.nbd.2014.08.023_bb0075","first-page":"3","article-title":"Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment","volume":"62","author":"Colussi","year":"2010","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"key":"10.1016\/j.nbd.2014.08.023_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2119\/molmed.2013.00011","article-title":"Preclinical studies in the mdx mouse model of Duchenne muscular dystrophy with the histone deacetylase inhibitor Givinostat","volume":"19","author":"Consalvi","year":"2013","journal-title":"Mol. Med. Camb. Mass."},{"key":"10.1016\/j.nbd.2014.08.023_bb0085","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0090","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/mus.20352","article-title":"Cardiac involvement in muscular dystrophies: molecular mechanisms","volume":"32","author":"Goodwin","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2044-5040-1-8","article-title":"Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy","volume":"1","author":"Goyenvalle","year":"2011","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.nbd.2014.08.023_bb0100","doi-asserted-by":"crossref","first-page":"e11220","DOI":"10.1371\/journal.pone.0011220","article-title":"Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy","volume":"5","author":"Guerron","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.023_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2353\/ajpath.2009.080537","article-title":"Valproic acid activates the PI3K\/Akt\/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy","volume":"174","author":"Gurpur","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","article-title":"L-arginine decreases inflammation and modulates the nuclear factor-kappaB\/matrix metalloproteinase cascade in mdx muscle fibers","volume":"172","author":"Hnia","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mus.880130105","article-title":"Excitation contraction coupling in normal and mdx mice","volume":"13","author":"Hollingworth","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0120","doi-asserted-by":"crossref","first-page":"14126","DOI":"10.1073\/pnas.241380298","article-title":"Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection","volume":"98","author":"Kanai","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.023_bb0125","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1073\/pnas.0710595105","article-title":"Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency","volume":"105","author":"Khairallah","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.023_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1529-8027.2008.00155.x","article-title":"Assessment of nerve excitability in toxic and metabolic neuropathies","volume":"13","author":"Krishnan","year":"2008","journal-title":"J. Peripher. Nerv. Syst. JPNS"},{"key":"10.1016\/j.nbd.2014.08.023_bb0140","first-page":"1970","article-title":"Progression of kyphosis in mdx mice","volume":"97","author":"Laws","year":"2004","journal-title":"J. Appl. Physiol. Bethesda Md 1985"},{"key":"10.1016\/j.nbd.2014.08.023_bb0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/BF01187915","article-title":"Structure and function of the neuromuscular junction in young adult mdx mice","volume":"20","author":"Lyons","year":"1991","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1556\/ABiol.61.2010.2.5","article-title":"Myocardial fibrosis is unaltered by long-term administration of L-arginine in dystrophin deficient mdx mice: a histomorphometric analysis","volume":"61","author":"Marques","year":"2010","journal-title":"Acta Biol. Hung."},{"key":"10.1016\/j.nbd.2014.08.023_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ar.20421","article-title":"2007. Nerve terminal contributes to acetylcholine receptor organization at the dystrophic neuromuscular junction of mdx mice","volume":"290","author":"Marques","year":"2007","journal-title":"Anat. Rec. Hoboken NJ"},{"key":"10.1016\/j.nbd.2014.08.023_bb0160","first-page":"237","article-title":"Stem cell therapies to treat muscular dystrophy: progress to date","volume":"24","author":"Meregalli","year":"2010","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"10.1016\/j.nbd.2014.08.023_bb0165","first-page":"83","article-title":"Autopsy analyses of the muscular dystrophies","volume":"40","author":"Moriuchi","year":"1993","journal-title":"Tokushima J. Exp. Med."},{"key":"10.1016\/j.nbd.2014.08.023_bb0170","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/mus.880130813","article-title":"Neuromuscular transmission in the mdx mouse","volume":"13","author":"Nagel","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2014.08.023_bb0175","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01241398-199307000-00012","article-title":"Longitudinal study of spinal deformity in Duchenne muscular dystrophy","volume":"13","author":"Oda","year":"1993","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.nbd.2014.08.023_bb0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3928\/00904481-20080501-10","article-title":"Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential","volume":"37","author":"Perrine","year":"2008","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.nbd.2014.08.023_bb0185","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/hmg\/dds047","article-title":"Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice","volume":"21","author":"Perronnet","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.023_bb0190","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/mt.2011.59","article-title":"Current status of pharmaceutical and genetic therapeutic approaches to treat DMD","volume":"19","author":"Pichavant","year":"2011","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.nbd.2014.08.023_bb0195","first-page":"24","article-title":"Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results","volume":"31","author":"Politano","year":"2012","journal-title":"Acta Myol. Myopathies Cardiomyopathies Off. J. Mediterr. Soc. Myol. Ed. Gaetano Conte Acad. Study Striated Muscle Dis."},{"key":"10.1016\/j.nbd.2014.08.023_bb0200","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.1016\/j.nbd.2014.08.023_bb0205","article-title":"Nitric oxide signaling pathway in Duchenne muscular dystrophy mice: upregulation of L-arginine transporters","author":"Ramachandran","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2014.08.023_bb0210","first-page":"210","article-title":"A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy","volume":"64","author":"Sciorati","year":"2011","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"key":"10.1016\/j.nbd.2014.08.023_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.yexcr.2004.09.007","article-title":"CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy","volume":"302","author":"S\u00e9galat","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.nbd.2014.08.023_bb0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.nmd.2008.03.008","article-title":"Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart","volume":"18","author":"Spurney","year":"2008","journal-title":"Neuromuscul. Disord. NMD"},{"key":"10.1016\/j.nbd.2014.08.023_bb0225","doi-asserted-by":"crossref","first-page":"e49350","DOI":"10.1371\/journal.pone.0049350","article-title":"Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy","volume":"7","author":"Thomas","year":"2012","journal-title":"PLoS One"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2014.08.023_bb0230","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/110.2.269","article-title":"The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates","volume":"110","author":"Torres","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2014.08.023_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu033","article-title":"Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy","author":"Uaesoontrachoon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.023_bb0240","first-page":"2603","article-title":"Low doses of arginine butyrate derivatives improve dystrophic phenotype and restore membrane integrity in DMD models","volume":"28","author":"Vianello","year":"2014","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0245","first-page":"2256","article-title":"Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy","volume":"27","author":"Vianello","year":"2013","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.nbd.2014.08.023_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2005.02.010","article-title":"L-arginine improves dystrophic phenotype in mdx mice","volume":"20","author":"Voisin","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.08.023_bb0255","doi-asserted-by":"crossref","first-page":"e10763","DOI":"10.1371\/journal.pone.0010763","article-title":"Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy","volume":"5","author":"Wehling-Henricks","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.08.023_bb0260","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/hmg\/ddi197","article-title":"Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium","volume":"14","author":"Wehling-Henricks","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2014.08.023_bb0265","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.96.2.657","article-title":"Nitric oxide synthase in cardiac sarcoplasmic reticulum","volume":"96","author":"Xu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.08.023_bb0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0028-3886.43441","article-title":"Duchenne muscular dystrophy","volume":"56","author":"Yiu","year":"2008","journal-title":"Neurol. India"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611400254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999611400254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T10:33:02Z","timestamp":1746354782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999611400254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":54,"alternative-id":["S096999611400254X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.023","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}